-1.04% $74.86

Hologic Inc is listed at the NASDAQ Exchange
Hologic Inc [HOLX]
Exchange: Nasdaq Global Select Industry: Medical Instruments & Supplies

America/New_York / 15 mai 2024 @ 16:00

Live Signal Hologic Inc

Signal :
NASDAQ: 1.40% | HOLX: -1.04% | Avg BUY signal:0.07 % | Avg SELL signal: -0.03%
Forecast 1: 16:00 - $74.88
Forecast 2: 16:00 - $74.88
Forecast 3: 16:00 - $74.88

Buy @ $75.56

Issued: 15 mai 2024 @ 10:47 / Return: -0.93%

Previous Signal: sell @ 14 mai 2024 @ 14:37 - Return: 0.68 %

$1 invested is now $1.05 or 4.53 % *

(* In 14 weeks 1 day 14 hours 39 minutes and 41 seconds .)

Dividend: X | Profitable: Y | Good Trading Volume: Y

About Hologic Inc

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Last live signals for Hologic Inc

The Live signals presented on this page help you to determine when to buy or sell Hologic Inc. The signals has upwards to 1 minute delay and like all signals there is an given chance for error or mistakes. The signals are not definite and stockinvestor.us hold no responsibility for any action taken upon these signals as clearly described in the TOS. The signals is based on technical analysis based on a wide range of indicators.

Right now there is a buy signal in the stock from the rsi14 signal,and we believe current price holds an opportunity to make profit.

Answer last updated: 15 mai 2024 @ 16:00

We cannot find any recorded dividends paid in our systems.

Yes, the consensus target for Hologic Inc is $82.45, which is $7.59, or 10.14 % above today's price. The analysts has low target of $70.00 and a high target of $95.00

We cannot find data for Hologic Inc 10 years ago, but if you had invested on Friday 17th of May 2019 when price was $44.87 you would have made a profit of $29.99 per share or 66.84 %

Yes, the average daily trading liquidity for Hologic Inc is $1 605 034 . You should therefore be able to get in and out of your positions relatively fast.

Hologic Inc has a normal ratio of the business financed by loans. This put the company at some risk in periods of high inflation where cost of borrowing money usually go up. With a normal cash flow to debt ratio of 0.43 the company's ability to pay of the debt is normal. Hologic Inc has a good net profit margin of 11.78% and should have high tolerances against inflation as the profit margin can be reduced to maintain market positions and overall sales.

We have calculated the inflation risk for Hologic Inc to be low [0.4 of 1]

US inflation for March 2024 was 0.38%. Over last 12 months the US inflation is 3.48%. The 10 year treasury yield that indicate the future interest level is currently 4.36 and is up 0.47 over last 30 days.

Disclaimer:

"StockInvestor.us" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "StockInvestor.us". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 0.48210096359253 seconds